Aurora Cannabis Inc (ACB) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.88 is considered Undervalued compared with the five-year average of -57.48. The fair price of Aurora Cannabis Inc (ACB) is between 7.10 to 24.20 according to relative valuation method. Compared to the current price of 3.74 USD , Aurora Cannabis Inc By Undervalued By 47.33%.

Relative Value

Fair Zone

7.10-24.20

Current Price：3.74

47.33%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Aurora Cannabis Inc (ACB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Aurora Cannabis Inc (ACB) has a current Price-to-Book (P/B) ratio of 0.63. Compared to its 3-year average P/B ratio of 8.95, the current P/B ratio is approximately -92.92% higher. Relative to its 5-year average P/B ratio of 5.58, the current P/B ratio is about -88.64% higher. Aurora Cannabis Inc (ACB) has a Forward Free Cash Flow (FCF) yield of approximately -5.44%. Compared to its 3-year average FCF yield of -24.81%, the current FCF yield is approximately -78.08% lower. Relative to its 5-year average FCF yield of -22.66%, the current FCF yield is about -76.01% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ACB competitors is 6.62, providing a benchmark for relative valuation. Aurora Cannabis Inc Corp (ACB.O) exhibits a P/S ratio of 0.88, which is -86.68% above the industry average. Given its robust revenue growth of 6.79%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ACB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ACB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ACB currently overvalued or undervalued?

What is Aurora Cannabis Inc (ACB) fair value?

ACB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Aurora Cannabis Inc (ACB) is between 7.10 to 24.20 according to relative valuation method.

How does ACB's valuation metrics compare to the industry average?

The average P/S ratio for ACB's competitors is 6.62, providing a benchmark for relative valuation. Aurora Cannabis Inc Corp (ACB) exhibits a P/S ratio of 0.88, which is -86.68% above the industry average. Given its robust revenue growth of 6.79%, this premium appears unsustainable.

What is the current P/B ratio for Aurora Cannabis Inc (ACB) as of Mar 02 2026?

As of Mar 02 2026, Aurora Cannabis Inc (ACB) has a P/B ratio of 0.63. This indicates that the market values ACB at 0.63 times its book value.

What is the current FCF Yield for Aurora Cannabis Inc (ACB) as of Mar 02 2026?

As of Mar 02 2026, Aurora Cannabis Inc (ACB) has a FCF Yield of -5.44%. This means that for every dollar of Aurora Cannabis Inc's market capitalization, the company generates -5.44 cents in free cash flow.

What is the current Forward P/E ratio for Aurora Cannabis Inc (ACB) as of Mar 02 2026?

As of Mar 02 2026, Aurora Cannabis Inc (ACB) has a Forward P/E ratio of -19.87. This means the market is willing to pay $-19.87 for every dollar of Aurora Cannabis Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Aurora Cannabis Inc (ACB) as of Mar 02 2026?

As of Mar 02 2026, Aurora Cannabis Inc (ACB) has a Forward P/S ratio of 0.88. This means the market is valuing ACB at $0.88 for every dollar of expected revenue over the next 12 months.

ACB Valuation